The identified tissue-specific proteins, i.e., PGM, PEPCK, GDH, CS, SDH, DLST, DLD, OGDH, and FLCN, could serve as targets for new drugs against anisakiasis. The gene discussed is PCK2; the disease is anisakiasis.